CONMED Gross Profit 2010-2024 | CNMD

CONMED gross profit from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
CONMED Annual Gross Profit
(Millions of US $)
2024 $733
2023 $676
2022 $571
2021 $568
2020 $460
2019 $525
2018 $469
2017 $431
2016 $408
2015 $382
2014 $404
2013 $412
2012 $406
2011 $375
2010 $365
2009 $337
CONMED Quarterly Gross Profit
(Millions of US $)
2024-12-31 $198
2024-09-30 $179
2024-06-30 $184
2024-03-31 $172
2023-12-31 $182
2023-09-30 $168
2023-06-30 $171
2023-03-31 $155
2022-12-31 $132
2022-09-30 $152
2022-06-30 $152
2022-03-31 $136
2021-12-31 $156
2021-09-30 $142
2021-06-30 $141
2021-03-31 $128
2020-12-31 $136
2020-09-30 $134
2020-06-30 $72
2020-03-31 $119
2019-12-31 $142
2019-09-30 $130
2019-06-30 $131
2019-03-31 $121
2018-12-31 $133
2018-09-30 $111
2018-06-30 $116
2018-03-31 $110
2017-12-31 $124
2017-09-30 $103
2017-06-30 $105
2017-03-31 $100
2016-12-31 $107
2016-09-30 $101
2016-06-30 $102
2016-03-31 $98
2015-12-31 $102
2015-09-30 $94
2015-06-30 $93
2015-03-31 $92
2014-12-31 $104
2014-09-30 $96
2014-06-30 $101
2014-03-31 $103
2013-12-31 $111
2013-09-30 $95
2013-06-30 $103
2013-03-31 $103
2012-12-31 $107
2012-09-30 $98
2012-06-30 $100
2012-03-31 $101
2011-12-31 $96
2011-09-30 $91
2011-06-30 $91
2011-03-31 $96
2010-12-31 $91
2010-09-30 $89
2010-06-30 $94
2010-03-31 $92
2009-12-31 $96
2009-09-30 $88
2009-06-30 $77
2009-03-31 $76
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $1.895B $1.307B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.636B 20.70
Becton Dickinson (BDX) United States $65.447B 16.39
Cardinal Health (CAH) United States $30.771B 16.48
Straumann Holding AG (SAUHY) Switzerland $23.360B 0.00
Labcorp (LH) United States $20.840B 17.10
Cooper (COO) United States $17.701B 23.97
Align Technology (ALGN) United States $14.786B 28.09
West Pharmaceutical Services (WST) United States $14.725B 30.17
Henry Schein (HSIC) United States $9.731B 18.54
Merit Medical Systems (MMSI) United States $6.158B 31.45
DENTSPLY SIRONA (XRAY) United States $3.767B 10.24
Patterson (PDCO) United States $2.743B 14.65
STAAR Surgical (STAA) United States $0.830B 0.00
Lifevantage (LFVN) United States $0.211B 23.31
Pro-Dex (PDEX) United States $0.109B 16.58